Tactile Systems Technology, Inc. TCMD

Company Overview

Tactile Systems Technology, Inc. (NASDAQ: TCMD) is a U.S.-based medical technology company focused on developing and commercializing medical devices for the treatment of chronic diseases at home. The company primarily operates in the healthcare and durable medical equipment industries, with a focus on lymphatic and respiratory therapies. Its core products are designed to help manage chronic swelling conditions such as lymphedema and chronic venous insufficiency, as well as pulmonary conditions requiring airway clearance therapy. The company generates most of its revenue through direct sales and reimbursement-supported device prescriptions in the United States healthcare market.

The company’s principal business lines include the Compression Therapy segment and the Airway Clearance segment. Its flagship products include the Flexitouch system for lymphedema treatment, the Entre system for venous and lymphatic conditions, and the AffloVest respiratory therapy product. Tactile Systems primarily serves patients, physicians, hospitals, outpatient clinics, and integrated healthcare providers. The company was founded in 1995 and evolved from a specialty medical device developer into a focused chronic-care therapy provider with a direct-to-patient distribution model and reimbursement expertise that differentiates it within the home medical technology sector.